Home › Myasthenia Gravis › NCT06259071
MuSK Myasthenia 1000 Study
Genome Wide Association Study of Patients With Muscle Specific Kinase Myasthenia Gravis
Who can join
Ages 7 to 99 · All sexes
Full eligibility criteria
Inclusion Criteria: * Lab test confirming diagnosis of MuSK myasthenia gravis * Willingness to provide saliva sample via mail or in person Exclusion Criteria: * Inability to provide informed consent * Unwillingness to provide lab results of elevated muscle specific kinase antibody * Unwillingness to provide saliva sample
About the study
The MuSK myasthenia gravis 1000 study seeks to collect saliva samples from 1000 subjects with laboratory confirmed diagnosis of MuSK myasthenia to identify genetic variations associated with MuSK MG. The data collected may be used by researchers to gain a better understanding of the cause of MuSK MG and to identify biomarkers and targeted therapy for MuSK MG.
Sponsor: George Washington University · Participants: 1,000 · Started: Aug 23, 2023
Contact the study team
- Gulsen Oztosun, MD · Phone: 202-677-6109
Official record on ClinicalTrials.gov — NCT06259071
Locations in the U.S.
| District of Columbia | George Washington University, Washington D.C. |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.